nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—PNP—respiratory system—chronic obstructive pulmonary disease	0.0178	0.065	CbGeAlD
Cladribine—RRM2B—respiratory system—chronic obstructive pulmonary disease	0.0165	0.0603	CbGeAlD
Cladribine—POLE3—respiratory system—chronic obstructive pulmonary disease	0.0156	0.057	CbGeAlD
Cladribine—POLE2—lung—chronic obstructive pulmonary disease	0.0149	0.0546	CbGeAlD
Cladribine—SLC28A3—respiratory system—chronic obstructive pulmonary disease	0.0146	0.0534	CbGeAlD
Cladribine—RRM2B—connective tissue—chronic obstructive pulmonary disease	0.0145	0.0531	CbGeAlD
Cladribine—RRM2B—bronchus—chronic obstructive pulmonary disease	0.0136	0.0496	CbGeAlD
Cladribine—POLE3—bronchus—chronic obstructive pulmonary disease	0.0129	0.0469	CbGeAlD
Cladribine—RRM2B—trachea—chronic obstructive pulmonary disease	0.0122	0.0446	CbGeAlD
Cladribine—POLE3—trachea—chronic obstructive pulmonary disease	0.0115	0.0421	CbGeAlD
Cladribine—SLC28A3—trachea—chronic obstructive pulmonary disease	0.0108	0.0394	CbGeAlD
Cladribine—RRM2—respiratory system—chronic obstructive pulmonary disease	0.00981	0.0358	CbGeAlD
Cladribine—PNP—lung—chronic obstructive pulmonary disease	0.00945	0.0345	CbGeAlD
Cladribine—POLE—trachea—chronic obstructive pulmonary disease	0.0088	0.0321	CbGeAlD
Cladribine—RRM2B—lung—chronic obstructive pulmonary disease	0.00877	0.032	CbGeAlD
Cladribine—POLE3—lung—chronic obstructive pulmonary disease	0.00829	0.0303	CbGeAlD
Cladribine—RRM1—respiratory system—chronic obstructive pulmonary disease	0.00815	0.0298	CbGeAlD
Cladribine—RRM2—bronchus—chronic obstructive pulmonary disease	0.00807	0.0295	CbGeAlD
Cladribine—SLC28A3—lung—chronic obstructive pulmonary disease	0.00776	0.0283	CbGeAlD
Cladribine—RRM1—bronchus—chronic obstructive pulmonary disease	0.00671	0.0245	CbGeAlD
Cladribine—RRM1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00656	0.024	CbGeAlD
Cladribine—POLE—lung—chronic obstructive pulmonary disease	0.00633	0.0231	CbGeAlD
Cladribine—POLA1—lung—chronic obstructive pulmonary disease	0.00545	0.0199	CbGeAlD
Cladribine—DCK—bronchus—chronic obstructive pulmonary disease	0.00521	0.019	CbGeAlD
Cladribine—RRM2—lung—chronic obstructive pulmonary disease	0.00521	0.019	CbGeAlD
Cladribine—DCK—trachea—chronic obstructive pulmonary disease	0.00468	0.0171	CbGeAlD
Cladribine—RRM1—lung—chronic obstructive pulmonary disease	0.00433	0.0158	CbGeAlD
Cladribine—DCK—lung—chronic obstructive pulmonary disease	0.00336	0.0123	CbGeAlD
Cladribine—ABCG2—lung—chronic obstructive pulmonary disease	0.00188	0.00685	CbGeAlD
Cladribine—PNP—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00167	0.13	CbGdCrCtD
Cladribine—PNP—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00165	0.129	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00163	0.127	CbGdCrCtD
Cladribine—PNP—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00161	0.126	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00147	0.114	CbGdCrCtD
Cladribine—PNP—Danazol—Prednisone—chronic obstructive pulmonary disease	0.00126	0.0987	CbGdCrCtD
Cladribine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00159	CcSEcCtD
Cladribine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00159	CcSEcCtD
Cladribine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00159	CcSEcCtD
Cladribine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00159	CcSEcCtD
Cladribine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00159	CcSEcCtD
Cladribine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.00157	CcSEcCtD
Cladribine—Cough—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00155	CcSEcCtD
Cladribine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00155	CcSEcCtD
Cladribine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00155	CcSEcCtD
Cladribine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00155	CcSEcCtD
Cladribine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00155	CcSEcCtD
Cladribine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00155	CcSEcCtD
Cladribine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00155	CcSEcCtD
Cladribine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00155	CcSEcCtD
Cladribine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00155	CcSEcCtD
Cladribine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00154	CcSEcCtD
Cladribine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00154	CcSEcCtD
Cladribine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00154	CcSEcCtD
Cladribine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00154	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00154	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00154	CcSEcCtD
Cladribine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00153	CcSEcCtD
Cladribine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00153	CcSEcCtD
Cladribine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00152	CcSEcCtD
Cladribine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00152	CcSEcCtD
Cladribine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00151	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00107	0.0015	CcSEcCtD
Cladribine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.0015	CcSEcCtD
Cladribine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.0015	CcSEcCtD
Cladribine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00148	CcSEcCtD
Cladribine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00148	CcSEcCtD
Cladribine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00148	CcSEcCtD
Cladribine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00147	CcSEcCtD
Cladribine—Infection—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00147	CcSEcCtD
Cladribine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00146	CcSEcCtD
Cladribine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00146	CcSEcCtD
Cladribine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00146	CcSEcCtD
Cladribine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00146	CcSEcCtD
Cladribine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00146	CcSEcCtD
Cladribine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00145	CcSEcCtD
Cladribine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00145	CcSEcCtD
Cladribine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00145	CcSEcCtD
Cladribine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00145	CcSEcCtD
Cladribine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00145	CcSEcCtD
Cladribine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00145	CcSEcCtD
Cladribine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00144	CcSEcCtD
Cladribine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00144	CcSEcCtD
Cladribine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00144	CcSEcCtD
Cladribine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00144	CcSEcCtD
Cladribine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00144	CcSEcCtD
Cladribine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00144	CcSEcCtD
Cladribine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00142	CcSEcCtD
Cladribine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00142	CcSEcCtD
Cladribine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00142	CcSEcCtD
Cladribine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.001	0.00141	CcSEcCtD
Cladribine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000993	0.0014	CcSEcCtD
Cladribine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000986	0.00139	CcSEcCtD
Cladribine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000983	0.00139	CcSEcCtD
Cladribine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000983	0.00139	CcSEcCtD
Cladribine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000978	0.00138	CcSEcCtD
Cladribine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000976	0.00138	CcSEcCtD
Cladribine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000974	0.00137	CcSEcCtD
Cladribine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000969	0.00137	CcSEcCtD
Cladribine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000964	0.00136	CcSEcCtD
Cladribine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00096	0.00135	CcSEcCtD
Cladribine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00096	0.00135	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000958	0.00135	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000958	0.00135	CcSEcCtD
Cladribine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000951	0.00134	CcSEcCtD
Cladribine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000951	0.00134	CcSEcCtD
Cladribine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000947	0.00133	CcSEcCtD
Cladribine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000945	0.00133	CcSEcCtD
Cladribine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000941	0.00133	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000938	0.00132	CcSEcCtD
Cladribine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000938	0.00132	CcSEcCtD
Cladribine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000938	0.00132	CcSEcCtD
Cladribine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000935	0.00132	CcSEcCtD
Cladribine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000935	0.00132	CcSEcCtD
Cladribine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000932	0.00131	CcSEcCtD
Cladribine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000928	0.00131	CcSEcCtD
Cladribine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000925	0.0013	CcSEcCtD
Cladribine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000922	0.0013	CcSEcCtD
Cladribine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000916	0.00129	CcSEcCtD
Cladribine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000914	0.00129	CcSEcCtD
Cladribine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000908	0.00128	CcSEcCtD
Cladribine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000908	0.00128	CcSEcCtD
Cladribine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000907	0.00128	CcSEcCtD
Cladribine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000907	0.00128	CcSEcCtD
Cladribine—DCK—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.000906	0.0707	CbGdCrCtD
Cladribine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000905	0.00128	CcSEcCtD
Cladribine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000899	0.00127	CcSEcCtD
Cladribine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000899	0.00127	CcSEcCtD
Cladribine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000899	0.00127	CcSEcCtD
Cladribine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000899	0.00127	CcSEcCtD
Cladribine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000898	0.00127	CcSEcCtD
Cladribine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000892	0.00126	CcSEcCtD
Cladribine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000889	0.00125	CcSEcCtD
Cladribine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000888	0.00125	CcSEcCtD
Cladribine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000885	0.00125	CcSEcCtD
Cladribine—DCK—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.000884	0.069	CbGdCrCtD
Cladribine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000883	0.00124	CcSEcCtD
Cladribine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000881	0.00124	CcSEcCtD
Cladribine—DCK—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.000879	0.0686	CbGdCrCtD
Cladribine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000879	0.00124	CcSEcCtD
Cladribine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000874	0.00123	CcSEcCtD
Cladribine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000871	0.00123	CcSEcCtD
Cladribine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00087	0.00123	CcSEcCtD
Cladribine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000868	0.00122	CcSEcCtD
Cladribine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000867	0.00122	CcSEcCtD
Cladribine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000867	0.00122	CcSEcCtD
Cladribine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000866	0.00122	CcSEcCtD
Cladribine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000863	0.00122	CcSEcCtD
Cladribine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000863	0.00122	CcSEcCtD
Cladribine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000862	0.00122	CcSEcCtD
Cladribine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00086	0.00121	CcSEcCtD
Cladribine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00086	0.00121	CcSEcCtD
Cladribine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000859	0.00121	CcSEcCtD
Cladribine—DCK—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.000858	0.0669	CbGdCrCtD
Cladribine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000857	0.00121	CcSEcCtD
Cladribine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000856	0.00121	CcSEcCtD
Cladribine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000849	0.0012	CcSEcCtD
Cladribine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000849	0.0012	CcSEcCtD
Cladribine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000842	0.00119	CcSEcCtD
Cladribine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000835	0.00118	CcSEcCtD
Cladribine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000835	0.00118	CcSEcCtD
Cladribine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000831	0.00117	CcSEcCtD
Cladribine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000831	0.00117	CcSEcCtD
Cladribine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000831	0.00117	CcSEcCtD
Cladribine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000831	0.00117	CcSEcCtD
Cladribine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000828	0.00117	CcSEcCtD
Cladribine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000822	0.00116	CcSEcCtD
Cladribine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000821	0.00116	CcSEcCtD
Cladribine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000821	0.00116	CcSEcCtD
Cladribine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000818	0.00115	CcSEcCtD
Cladribine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000818	0.00115	CcSEcCtD
Cladribine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000816	0.00115	CcSEcCtD
Cladribine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000814	0.00115	CcSEcCtD
Cladribine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000814	0.00115	CcSEcCtD
Cladribine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000812	0.00114	CcSEcCtD
Cladribine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000806	0.00114	CcSEcCtD
Cladribine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000802	0.00113	CcSEcCtD
Cladribine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000789	0.00111	CcSEcCtD
Cladribine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000785	0.00111	CcSEcCtD
Cladribine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000785	0.00111	CcSEcCtD
Cladribine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000775	0.00109	CcSEcCtD
Cladribine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000775	0.00109	CcSEcCtD
Cladribine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000774	0.00109	CcSEcCtD
Cladribine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000759	0.00107	CcSEcCtD
Cladribine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000755	0.00106	CcSEcCtD
Cladribine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000755	0.00106	CcSEcCtD
Cladribine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000744	0.00105	CcSEcCtD
Cladribine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000744	0.00105	CcSEcCtD
Cladribine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000743	0.00105	CcSEcCtD
Cladribine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000739	0.00104	CcSEcCtD
Cladribine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000732	0.00103	CcSEcCtD
Cladribine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000729	0.00103	CcSEcCtD
Cladribine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00072	0.00101	CcSEcCtD
Cladribine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00072	0.00101	CcSEcCtD
Cladribine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000716	0.00101	CcSEcCtD
Cladribine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000712	0.001	CcSEcCtD
Cladribine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000709	0.001	CcSEcCtD
Cladribine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000705	0.000994	CcSEcCtD
Cladribine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000703	0.000991	CcSEcCtD
Cladribine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000698	0.000984	CcSEcCtD
Cladribine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000695	0.000981	CcSEcCtD
Cladribine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000695	0.000981	CcSEcCtD
Cladribine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000681	0.00096	CcSEcCtD
Cladribine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000681	0.00096	CcSEcCtD
Cladribine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000679	0.000958	CcSEcCtD
Cladribine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000669	0.000943	CcSEcCtD
Cladribine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000669	0.000943	CcSEcCtD
Cladribine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000663	0.000935	CcSEcCtD
Cladribine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000663	0.000935	CcSEcCtD
Cladribine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000662	0.000934	CcSEcCtD
Cladribine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000662	0.000934	CcSEcCtD
Cladribine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000659	0.000929	CcSEcCtD
Cladribine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000659	0.000929	CcSEcCtD
Cladribine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000657	0.000926	CcSEcCtD
Cladribine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000655	0.000923	CcSEcCtD
Cladribine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000649	0.000916	CcSEcCtD
Cladribine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000649	0.000915	CcSEcCtD
Cladribine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000647	0.000913	CcSEcCtD
Cladribine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000645	0.00091	CcSEcCtD
Cladribine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000631	0.00089	CcSEcCtD
Cladribine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000629	0.000887	CcSEcCtD
Cladribine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000626	0.000883	CcSEcCtD
Cladribine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000626	0.000882	CcSEcCtD
Cladribine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000625	0.000881	CcSEcCtD
Cladribine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000625	0.000881	CcSEcCtD
Cladribine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.000877	CcSEcCtD
Cladribine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000612	0.000863	CcSEcCtD
Cladribine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00059	0.000832	CcSEcCtD
Cladribine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000587	0.000828	CcSEcCtD
Cladribine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000585	0.000826	CcSEcCtD
Cladribine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000583	0.000821	CcSEcCtD
Cladribine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000807	CcSEcCtD
Cladribine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00057	0.000803	CcSEcCtD
Cladribine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000556	0.000784	CcSEcCtD
Cladribine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000551	0.000776	CcSEcCtD
Cladribine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000544	0.000768	CcSEcCtD
Cladribine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000529	0.000745	CcSEcCtD
Cladribine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000526	0.000742	CcSEcCtD
Cladribine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00052	0.000734	CcSEcCtD
Cladribine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000515	0.000726	CcSEcCtD
Cladribine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000515	0.000726	CcSEcCtD
Cladribine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000511	0.000721	CcSEcCtD
Cladribine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00051	0.00072	CcSEcCtD
Cladribine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000507	0.000715	CcSEcCtD
Cladribine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000507	0.000715	CcSEcCtD
Cladribine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000487	0.000687	CcSEcCtD
Cladribine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00047	0.000663	CcSEcCtD
Cladribine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000469	0.000662	CcSEcCtD
Cladribine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000469	0.000661	CcSEcCtD
Cladribine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000457	0.000645	CcSEcCtD
Cladribine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000452	0.000638	CcSEcCtD
Cladribine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000432	0.000609	CcSEcCtD
Cladribine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000432	0.000609	CcSEcCtD
Cladribine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00043	0.000607	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000429	0.000605	CcSEcCtD
Cladribine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000427	0.000601	CcSEcCtD
Cladribine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00042	0.000592	CcSEcCtD
Cladribine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000414	0.000584	CcSEcCtD
Cladribine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000411	0.00058	CcSEcCtD
Cladribine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000406	0.000572	CcSEcCtD
Cladribine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000404	0.00057	CcSEcCtD
Cladribine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000402	0.000567	CcSEcCtD
Cladribine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.0004	0.000564	CcSEcCtD
Cladribine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000394	0.000556	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000377	0.000532	CcSEcCtD
Cladribine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.000531	CcSEcCtD
Cladribine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000374	0.000528	CcSEcCtD
Cladribine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000372	0.000524	CcSEcCtD
Cladribine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00036	0.000507	CcSEcCtD
Cladribine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.000506	CcSEcCtD
Cladribine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.000506	CcSEcCtD
Cladribine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000357	0.000503	CcSEcCtD
Cladribine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000357	0.000503	CcSEcCtD
Cladribine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000354	0.000499	CcSEcCtD
Cladribine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000341	0.000481	CcSEcCtD
Cladribine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000338	0.000477	CcSEcCtD
Cladribine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000338	0.000477	CcSEcCtD
Cladribine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000464	CcSEcCtD
Cladribine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000327	0.000461	CcSEcCtD
Cladribine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000327	0.000461	CcSEcCtD
Cladribine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00043	CcSEcCtD
Cladribine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000297	0.000419	CcSEcCtD
Cladribine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000413	CcSEcCtD
Cladribine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000399	CcSEcCtD
Cladribine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000386	CcSEcCtD
Cladribine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000263	0.000371	CcSEcCtD
Cladribine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000261	0.000368	CcSEcCtD
Cladribine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000261	0.000368	CcSEcCtD
Cladribine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000366	CcSEcCtD
Cladribine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000347	CcSEcCtD
Cladribine—RRM2B—Direct p53 effectors—HDAC2—chronic obstructive pulmonary disease	0.000143	0.0348	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000124	0.0303	CbGpPWpGaD
Cladribine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000121	0.0295	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000112	0.0273	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.99e-05	0.0243	CbGpPWpGaD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—MMP14—chronic obstructive pulmonary disease	9.3e-05	0.0227	CbGpPWpGaD
Cladribine—RRM1—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	7.58e-05	0.0185	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—APIP—chronic obstructive pulmonary disease	7e-05	0.0171	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	7e-05	0.0171	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—SERPINE1—chronic obstructive pulmonary disease	6.99e-05	0.017	CbGpPWpGaD
Cladribine—RRM2B—DNA Damage Response—TP53—chronic obstructive pulmonary disease	6.47e-05	0.0158	CbGpPWpGaD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—TP53—chronic obstructive pulmonary disease	6.25e-05	0.0152	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	6.24e-05	0.0152	CbGpPWpGaD
Cladribine—PNP—Metabolism—APIP—chronic obstructive pulmonary disease	6.07e-05	0.0148	CbGpPWpGaD
Cladribine—RRM1—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.86e-05	0.0143	CbGpPWpGaD
Cladribine—RRM1—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	5.75e-05	0.014	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	4.83e-05	0.0118	CbGpPWpGaD
Cladribine—RRM2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	4.73e-05	0.0115	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.64e-05	0.0113	CbGpPWpGaD
Cladribine—ABCG2—Iron uptake and transport—HMOX1—chronic obstructive pulmonary disease	4.58e-05	0.0112	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GC—chronic obstructive pulmonary disease	4.51e-05	0.011	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—EGFR—chronic obstructive pulmonary disease	4.33e-05	0.0105	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	4.27e-05	0.0104	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.2e-05	0.0102	CbGpPWpGaD
Cladribine—PNP—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.02e-05	0.0098	CbGpPWpGaD
Cladribine—POLE2—G1 to S cell cycle control—TP53—chronic obstructive pulmonary disease	3.95e-05	0.00964	CbGpPWpGaD
Cladribine—PNP—Metabolism—GC—chronic obstructive pulmonary disease	3.91e-05	0.00954	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	3.83e-05	0.00933	CbGpPWpGaD
Cladribine—PNP—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.64e-05	0.00887	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—TP53—chronic obstructive pulmonary disease	3.63e-05	0.00885	CbGpPWpGaD
Cladribine—RRM1—Metabolism—APIP—chronic obstructive pulmonary disease	3.49e-05	0.0085	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	3.37e-05	0.00821	CbGpPWpGaD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	3.33e-05	0.00811	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	3.3e-05	0.00804	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	3.25e-05	0.00793	CbGpPWpGaD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	3.25e-05	0.00791	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	3.07e-05	0.00747	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	2.94e-05	0.00717	CbGpPWpGaD
Cladribine—RRM2—Metabolism—APIP—chronic obstructive pulmonary disease	2.87e-05	0.007	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.81e-05	0.00686	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.78e-05	0.00678	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	2.74e-05	0.00668	CbGpPWpGaD
Cladribine—DCK—Metabolism—APIP—chronic obstructive pulmonary disease	2.68e-05	0.00654	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	2.65e-05	0.00645	CbGpPWpGaD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.6e-05	0.00633	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.59e-05	0.00632	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—TP53—chronic obstructive pulmonary disease	2.55e-05	0.00621	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.51e-05	0.00611	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	2.49e-05	0.00608	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.48e-05	0.00605	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.47e-05	0.00601	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GCLC—chronic obstructive pulmonary disease	2.44e-05	0.00594	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	2.4e-05	0.00584	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	2.32e-05	0.00566	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.31e-05	0.00564	CbGpPWpGaD
Cladribine—RRM1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.31e-05	0.00563	CbGpPWpGaD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	2.29e-05	0.00558	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	2.25e-05	0.00549	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GC—chronic obstructive pulmonary disease	2.25e-05	0.00548	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	2.23e-05	0.00545	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CTGF—chronic obstructive pulmonary disease	2.22e-05	0.00542	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.2e-05	0.00536	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	2.18e-05	0.00531	CbGpPWpGaD
Cladribine—PNP—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.14e-05	0.00521	CbGpPWpGaD
Cladribine—PNP—Metabolism—GCLC—chronic obstructive pulmonary disease	2.11e-05	0.00515	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	2.1e-05	0.00512	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.09e-05	0.0051	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	2.09e-05	0.0051	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.09e-05	0.00509	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.05e-05	0.00499	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	2.04e-05	0.00496	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	1.96e-05	0.00477	CbGpPWpGaD
Cladribine—PNP—Metabolism—CTGF—chronic obstructive pulmonary disease	1.93e-05	0.0047	CbGpPWpGaD
Cladribine—RRM2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.9e-05	0.00464	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.87e-05	0.00455	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GC—chronic obstructive pulmonary disease	1.85e-05	0.00451	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.84e-05	0.00449	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	1.84e-05	0.00448	CbGpPWpGaD
Cladribine—DCK—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.78e-05	0.00433	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.00433	CbGpPWpGaD
Cladribine—ABCG2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	1.77e-05	0.00431	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.75e-05	0.00425	CbGpPWpGaD
Cladribine—DCK—Metabolism—GC—chronic obstructive pulmonary disease	1.73e-05	0.00421	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.72e-05	0.00419	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.72e-05	0.00419	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.71e-05	0.00418	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	1.71e-05	0.00417	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.71e-05	0.00416	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.69e-05	0.00411	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.68e-05	0.0041	CbGpPWpGaD
Cladribine—DCK—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.61e-05	0.00392	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.6e-05	0.0039	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.57e-05	0.00383	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	1.49e-05	0.00363	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.00363	CbGpPWpGaD
Cladribine—PNP—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.48e-05	0.00361	CbGpPWpGaD
Cladribine—PNP—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.46e-05	0.00356	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.41e-05	0.00344	CbGpPWpGaD
Cladribine—PNP—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.36e-05	0.00332	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	1.35e-05	0.00328	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.32e-05	0.00322	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.00315	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.26e-05	0.00307	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.23e-05	0.00299	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.21e-05	0.00296	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.13e-05	0.00275	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.11e-05	0.0027	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	1.07e-05	0.00262	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.06e-05	0.00259	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.05e-05	0.00256	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.04e-05	0.00253	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.02e-05	0.00249	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.02e-05	0.00248	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—ALB—chronic obstructive pulmonary disease	1.01e-05	0.00247	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.01e-05	0.00246	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.99e-06	0.00244	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	9.91e-06	0.00241	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TNF—chronic obstructive pulmonary disease	9.68e-06	0.00236	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—NOS3—chronic obstructive pulmonary disease	9.68e-06	0.00236	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	9.65e-06	0.00235	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.46e-06	0.00231	CbGpPWpGaD
Cladribine—DCK—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.45e-06	0.0023	CbGpPWpGaD
Cladribine—DCK—Metabolism—GCLC—chronic obstructive pulmonary disease	9.34e-06	0.00228	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.12e-06	0.00222	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.01e-06	0.0022	CbGpPWpGaD
Cladribine—PNP—Metabolism—ALB—chronic obstructive pulmonary disease	8.77e-06	0.00214	CbGpPWpGaD
Cladribine—DCK—Metabolism—CTGF—chronic obstructive pulmonary disease	8.52e-06	0.00208	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.51e-06	0.00207	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.4e-06	0.00205	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	8.4e-06	0.00205	CbGpPWpGaD
Cladribine—PNP—Metabolism—NOS3—chronic obstructive pulmonary disease	8.39e-06	0.00205	CbGpPWpGaD
Cladribine—RRM1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.39e-06	0.00205	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.95e-06	0.00194	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.85e-06	0.00191	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.82e-06	0.00191	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—IL6—chronic obstructive pulmonary disease	7.81e-06	0.0019	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—chronic obstructive pulmonary disease	7.49e-06	0.00183	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.41e-06	0.00181	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.11e-06	0.00173	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.04e-06	0.00172	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.01e-06	0.00171	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	6.92e-06	0.00169	CbGpPWpGaD
Cladribine—RRM2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.91e-06	0.00168	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	6.85e-06	0.00167	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.56e-06	0.0016	CbGpPWpGaD
Cladribine—DCK—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.55e-06	0.0016	CbGpPWpGaD
Cladribine—DCK—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.46e-06	0.00157	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.45e-06	0.00157	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.44e-06	0.00157	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.43e-06	0.00157	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	6.38e-06	0.00156	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.37e-06	0.00155	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.1e-06	0.00149	CbGpPWpGaD
Cladribine—DCK—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.02e-06	0.00147	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.01e-06	0.00147	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.93e-06	0.00145	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.7e-06	0.00139	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.52e-06	0.00134	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.46e-06	0.00133	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.09e-06	0.00124	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ALB—chronic obstructive pulmonary disease	5.04e-06	0.00123	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—chronic obstructive pulmonary disease	5.03e-06	0.00123	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—chronic obstructive pulmonary disease	4.83e-06	0.00118	CbGpPWpGaD
Cladribine—RRM1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.82e-06	0.00117	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ALB—chronic obstructive pulmonary disease	4.15e-06	0.00101	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.97e-06	0.000967	CbGpPWpGaD
Cladribine—DCK—Metabolism—ALB—chronic obstructive pulmonary disease	3.88e-06	0.000945	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.78e-06	0.000921	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.74e-06	0.000912	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.74e-06	0.000911	CbGpPWpGaD
Cladribine—DCK—Metabolism—NOS3—chronic obstructive pulmonary disease	3.71e-06	0.000904	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.7e-06	0.000901	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.49e-06	0.00085	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.45e-06	0.00084	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—chronic obstructive pulmonary disease	3.44e-06	0.000838	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.41e-06	0.000831	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.37e-06	0.000823	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.31e-06	0.000808	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.28e-06	0.000799	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.15e-06	0.000767	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.14e-06	0.000766	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.11e-06	0.000758	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.06e-06	0.000745	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.9e-06	0.000706	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.62e-06	0.000639	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.59e-06	0.000632	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.58e-06	0.00063	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.56e-06	0.000623	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.42e-06	0.000589	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.41e-06	0.000587	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.38e-06	0.000581	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.38e-06	0.000581	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.28e-06	0.000556	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.26e-06	0.000551	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.22e-06	0.000541	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.11e-06	0.000513	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.55e-06	0.000378	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.54e-06	0.000374	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.48e-06	0.000362	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.47e-06	0.000358	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.43e-06	0.000349	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.37e-06	0.000334	CbGpPWpGaD
